(Q52976044)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583765%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Cotreatment of hairy cell leukemia and melanoma with the BRAF inhibitor dabrafenib (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583765%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583765%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Gerard Lozanski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583765%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

David M Lucas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583765%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Michael R Grever

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583765%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Kari Kendra

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583765%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Leslie A Andritsos

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583765%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

publication date

1 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583765%20AND%20SRC:MED&resulttype=core&format=json

Journal of the National Comprehensive Cancer Network

27 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583765%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583765%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583765%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

9-13; quiz 13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25583765%20AND%20SRC:MED&resulttype=core&format=json

Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia

27 February 2020

cites work

1 reference

12 December 2020

BRAF Mutation in Papillary Thyroid Carcinoma

1 reference

12 December 2020

Germline mutation in BRAF codon 600 is compatible with human development: de novo p.V600G mutation identified in a patient with CFC syndrome

1 reference

12 December 2020

Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas

1 reference

12 December 2020

BRAF inhibition in refractory hairy-cell leukemia.

1 reference

12 December 2020

Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation

1 reference

12 December 2020

Frequency and spectrum of BRAF mutations in a retrospective, single-institution study of 1112 cases of melanoma

1 reference

12 December 2020

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations

1 reference

12 December 2020

BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer

1 reference

12 December 2020

Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations.

1 reference

12 December 2020

Poor Survival Associated with theBRAFV600E Mutation in Microsatellite-Stable Colon Cancers

1 reference

12 December 2020

BRAF mutations in hairy-cell leukemia

1 reference

12 December 2020

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

1 reference

12 December 2020

Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.

1 reference

12 December 2020

RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors

1 reference

12 December 2020

Clinicopathological relevance of BRAF mutations in human cancer

1 reference

12 December 2020